These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 33890983)
61. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease. Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204 [TBL] [Abstract][Full Text] [Related]
62. Shared signaling pathways in Alzheimer's and metabolic disease may point to new treatment approaches. Suresh J; Khor IW; Kaur P; Heng HL; Torta F; Dawe GS; Tai ES; Tolwinski NS FEBS J; 2021 Jun; 288(12):3855-3873. PubMed ID: 32853472 [TBL] [Abstract][Full Text] [Related]
63. Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling. Kang S; Kim CH; Jung H; Kim E; Song HT; Lee JE Neuropharmacology; 2017 Feb; 113(Pt A):467-479. PubMed ID: 27810390 [TBL] [Abstract][Full Text] [Related]
64. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization. Yoo G; Kim T; Chung C; Hwang DS; Lim DS Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071 [TBL] [Abstract][Full Text] [Related]
65. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590 [TBL] [Abstract][Full Text] [Related]
66. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease. Zhu C; Xu B; Sun X; Zhu Q; Sui Y Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757 [TBL] [Abstract][Full Text] [Related]
67. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644 [TBL] [Abstract][Full Text] [Related]
68. Combination of PKCε Activation and PTP1B Inhibition Effectively Suppresses Aβ-Induced GSK-3β Activation and Tau Phosphorylation. Kanno T; Tsuchiya A; Tanaka A; Nishizaki T Mol Neurobiol; 2016 Sep; 53(7):4787-97. PubMed ID: 26328540 [TBL] [Abstract][Full Text] [Related]
69. Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression. Cortés-Gómez MÁ; Llorens-Álvarez E; Alom J; Del Ser T; Avila J; Sáez-Valero J; García-Ayllón MS J Neurochem; 2021 Jun; 157(6):2091-2105. PubMed ID: 32955735 [TBL] [Abstract][Full Text] [Related]
70. SGK1 phosphorylation of IkappaB Kinase alpha and p300 Up-regulates NF-kappaB activity and increases N-Methyl-D-aspartate receptor NR2A and NR2B expression. Tai DJ; Su CC; Ma YL; Lee EH J Biol Chem; 2009 Feb; 284(7):4073-89. PubMed ID: 19088076 [TBL] [Abstract][Full Text] [Related]
71. 14-3-3 Protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1. Chun J; Kwon T; Lee EJ; Kim CH; Han YS; Hong SK; Hyun S; Kang SS Mol Cells; 2004 Dec; 18(3):360-8. PubMed ID: 15650334 [TBL] [Abstract][Full Text] [Related]
72. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease. Bose A; Mouton-Liger F; Paquet C; Mazot P; Vigny M; Gray F; Hugon J Brain Pathol; 2011 Mar; 21(2):189-200. PubMed ID: 21029237 [TBL] [Abstract][Full Text] [Related]
73. Sgk1 regulates desmoglein 1 expression levels in oligodendrocytes in the mouse corpus callosum after chronic stress exposure. Miyata S; Yoshikawa K; Taniguchi M; Ishikawa T; Tanaka T; Shimizu S; Tohyama M Biochem Biophys Res Commun; 2015 Aug; 464(1):76-82. PubMed ID: 26043694 [TBL] [Abstract][Full Text] [Related]
74. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. Farr SA; Ripley JL; Sultana R; Zhang Z; Niehoff ML; Platt TL; Murphy MP; Morley JE; Kumar V; Butterfield DA Free Radic Biol Med; 2014 Feb; 67():387-95. PubMed ID: 24355211 [TBL] [Abstract][Full Text] [Related]
75. Colorectal carcinoma cells--regulation of survival and growth by SGK1. Lang F; Perrotti N; Stournaras C Int J Biochem Cell Biol; 2010 Oct; 42(10):1571-5. PubMed ID: 20541034 [TBL] [Abstract][Full Text] [Related]
76. Resveratrol Ameliorates Tau Hyperphosphorylation at Ser396 Site and Oxidative Damage in Rat Hippocampal Slices Exposed to Vanadate: Implication of ERK1/2 and GSK-3β Signaling Cascades. Jhang KA; Park JS; Kim HS; Chong YH J Agric Food Chem; 2017 Nov; 65(44):9626-9634. PubMed ID: 29022339 [TBL] [Abstract][Full Text] [Related]
77. Protein kinase CK2 impairs spatial memory formation through differential cross talk with PI-3 kinase signaling: activation of Akt and inactivation of SGK1. Chao CC; Ma YL; Lee EH J Neurosci; 2007 Jun; 27(23):6243-8. PubMed ID: 17553997 [TBL] [Abstract][Full Text] [Related]
78. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice. Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882 [TBL] [Abstract][Full Text] [Related]
79. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Chatterjee S; Sang TK; Lawless GM; Jackson GR Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955 [TBL] [Abstract][Full Text] [Related]